Cantor Fitzgerald initiated coverage of TriSalus Life Sciences (TLSI) with an Overweight rating and $10 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSI:
Education
About Us
Working with TipRanks
Follow Us
